中生北控生物科技(08247)与小手医疗签署战略合作协议,共同推动优质医疗资源下沉及基层医疗服务能力提升

Core Viewpoint - The strategic cooperation agreement between Zhongsheng Beikong Biotechnology (08247) and Xiaoshou Medical aims to enhance the capacity of grassroots medical services and promote the distribution of quality medical resources [1] Group 1: Capital and Strategic Collaboration - The company plans to make a strategic investment in Xiaoshou Medical to establish a long-term stable partnership and explore innovative development models in the grassroots medical market [2] Group 2: Business and Resource Complementation - The company will leverage its advantages in in vitro diagnostics (IVD) products and R&D capabilities, combined with Xiaoshou Medical's nationwide grassroots medical channel network and digital platform, to deliver biochemical, immunological, and POCT products directly to grassroots medical institutions [3] - A joint working group will be established to enhance data insights, product development, and supply chain optimization while developing customized products and "smart testing solutions" suitable for grassroots medical scenarios [3] Group 3: Ecosystem and Value Co-Creation - The collaboration will integrate various resources such as equipment, reagents, operations, and data to provide one-stop testing service solutions for regional medical communities and chain clinics, thereby improving the overall testing capabilities and operational efficiency of grassroots medical institutions [4] - The cooperation will be implemented in phases, starting with strategic pilot verification and gradually expanding to large-scale implementation, while exploring deeper collaboration at the industrial and capital levels [4] - The board believes that this strategic cooperation will help the company integrate quality R&D capabilities with digital channel resources, accelerating the penetration of products and services into grassroots medical institutions, aligning with national initiatives to enhance the grassroots medical system and the "Healthy China" strategy [4]

BIOSINO BIO-TEC-中生北控生物科技(08247)与小手医疗签署战略合作协议,共同推动优质医疗资源下沉及基层医疗服务能力提升 - Reportify